Click here to view the Travel Award Winners for 2018

ISBER 2018 Outstanding Achievement in Biobanking – Jane Carpenter

Originally from the UK, Jane trained and worked as a biomedical scientist in diagnostic haematology. Migrating to Australia she moved into medical research to develop biobanking programs. Jane was an ISBER Board Member for 6 years and has been on many ISBER committees and working groups, including co-chairing the 2013 ISBER meeting in Sydney. She is a board member of the Asian Network of Research Resource Centres and chairs the Standards Australia Mirror Committee for ISO 276. Recently, Jane has worked with NSW Health Pathology on a range of projects to improve quality and practices of biobanking statewide. These include development of a Biobank certification program, evaluation of practices within pathology laboratories and trailing workflows to improve efficiencies, and standardisation of key documentation state-wide. Concurrently she led a major capital project to build and commission the NSW State-wide biobank facility which opened in late 2017. She is currently assisting Westmead Hub Biobanking programs.
 The ISBER Award for Outstanding Achievement in Biobanking, sponsored by Worthington Industries, is designed to recognize individuals who have made outstanding contributions to the field of biobanking. The award can be given for a single outstanding achievement or a life-time body of outstanding work in the field.

ISBER 2018 Founder’s Award – Jim Vaught

Dr. Jim Vaught spent 14 years at the U.S. National Cancer Institute, most recently as the Chief of the Biorepositories and Biospecimen Research Branch. He has been working in the field of biobanking and biospecimen science for over 20 years. In 1999, he was one of the founding members of ISBER and has served two terms as its president. His current work includes providing biobanking consulting services and serving on a number of advisory boards. He is the author of about 80 peer-reviewed articles and book chapters in chemical carcinogenesis and drug metabolism, as well as biobanking and biospecimen science. From 2006 to 2012 he was Senior Editor for Biospecimens and Biorepositories for the journal Cancer Epidemiology, Biomarkers and Prevention. He is the current Editor-in-Chief of Biopreservation and Biobanking, the official journal of ISBER. In 2017 he was appointed as a Guest Professor at Central South University in Changsha.
The ISBER Founders Award, sponsored by Chart MVE, recognizes individuals who have provided outstanding leadership to the founding, support, and incorporation of ISBER as an international biobanking society. The recipient of this award is selected by the ISBER Nominating Committee.

ISBER 2018 Distinguished Leadership & Service Award – Lori Campbell

Dr. Lori Campbell has over 15 years of experience in biobanking and repository management. She has been an active member of ISBER since 2004 and has served on the ISBER Board, Education & Training Committee, Publications Committee, and is the current Editor-in-Chief of the ISBER Best Practices. She earned her PhD in in Cellular and Molecular Immunology from Quillen College of Medicine. Her experience includes managing the R&D departments in clinical diagnostics laboratories and 10 years managing the CASPIR facility at the Centers for Disease Control and Prevention (CDC), which manages collections obtained from CDC’s public health surveillance, research, and outbreak responses. She joined the National Cancer Institute (NCI)’s Biospecimen Research Database project as a Curator in November 2015, performing literature curations and participating in the development and editing of publications and other work products on behalf of the NCI Biorepositories and Biospecimen Research Branch.
This award is designed to honor ISBER members who have demonstrated exceptional leadership to further the mission and goals of the society and/or significant, long-standing contributions to the society.

ISBER 2018 Special Service Award

Mark Barnes

For his contribution to ISBER in relation to federal legal aspects at the US Department of Health and Human Services.

  Mark is a partner at Ropes & Gray, where his client work focuses on human and animal research, stem cell and genetic research, research fraud, and international research. Mark formerly served at Harvard as the Senior Associate Provost for Research, and in 2004 started and directed for several years Harvard’s HIV/AIDS treatment programs in Nigeria, Tanzania and Botswana. He has served as chief administrative officer at St. Jude Children’s Research Hospital, and has held senior appointed positions in the New York City and State departments of health. Mark is co-chair of the Subcommittee on Harmonization of Research Regulations, HHS Secretary’s Advisory Committee on Human Subjects Protections, and is a member of the Ethics Working Group of the NIH HIV Prevention Clinical Trials Network.  He is faculty co-chair of the Multi-Regional Clinical Trials Center of Harvard and Brigham and Women’s Hospital, which works with researchers, industry and regulators to improve standards and regulations for clinical trials, with a focus on the emerging economies.  Mark teaches health law at Yale Law School.

Marianna Bledsoe

For her efforts on the Henrietta Lacks movie response, the links with the US federal Office for Human Research Protections and the US HHS Secretary’s Advisory Committee on Human Research Protections, and the initiative with Public Responsibility in Medicine and Research (PRIM&R).

  Marianna is an independent consultant and Deputy Editor for the journal, Biopreservation and Biobanking. She Chairs the ISBER Science Policy Committee and is a member of the ISBER ISO TC 276 Taskforce. Involved in biobanking for more than 20 years, Marianna provided scientific oversight for numerous biobanks at the National Cancer Institute and the Department of Veterans Affairs. In the National Institutes of Health Office of Science Policy, she participated in the development of federal policies, and national and international guidance related to biobanking, genomic data sharing, privacy and confidentiality, and health information technology. Marianna has taught and presented nationally and internationally on research ethics and biobanking issues. Marianna was ISBER President from 2007 – 2008. She received the ISBER Distinguished Leadership and Service Award in 2012, and ISBER Special Act or Service Awards in 2013 and 2015. Marianna received her Masters degree in organic chemistry from Johns Hopkins University.

Andy Brooks

For his long-term commitment and promotion of the applied side of the science of biobanking.

Since joining RUCDR, Dr. Brooks has worked to automate and develop the service infrastructure to provide high throughput sample management and analysis for DNA, RNA and protein-based technologies to hundreds of labs globally. As Chief Operating Officer he oversees all laboratories within RUCDR, ensuring consistent and superior quality standards for all services. His methodologies focus on extending the use of valuable samples by extracting and renewing limited quantities of biomaterial with newly developed technologies. Dr. Brooks is a molecular neuroscientist whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. These studies investigate gene-environment interactions in the context of aging, neurodegenerative disease and neurotoxicant exposure. Dr. Brooks is a well-recognized genomicist and has been involved in the development and implementation of cutting edge molecular based technologies for nucleic acid and protein analyses. Dr. Brooks has worked over the years with both academic and industry partners on the development of technologies and standards that focus on maximizing the use of biological samples while understanding both analytical and functional quality control. He has shared this information globally across many public and private biobank programs through a variety of academic and commercial activities.

Koh Furuta

For his long-term commitment and promotion of biobanking in Japan.

I was graduated from Kyushu University, Fukuoka Japan. I have started my career as a surgeon. I have spent 5 years at Johns Hopkins University from ‘92 to ’97. During that time I was exposed to the very early stage of molecular biology and biobanking. After returning to Japan, I spent 15 years at National Cancer Center Hospital in Tokyo. During this 15 years, I spent one winter at University of Minnesota to learn some basics of cryobiology as a short sabbatical. Then I was invited to move to Kanagawa Cancer Center Yokohama in 2015. During my work in National Cancer Center I was working with my colleague to establish a biobank of liquid samples especially of blood. Currently I am working as an official liaison between ISBER and ISO TC276 (biobanking), and an expert of ISO TC212 (Clinical Laboratory).

Marianne Henderson

For her outstanding contribution to the Global Biobank Week and Dallas conferences.

Ms. Henderson is Senior Advisor for Division Resources, Division of Cancer Epidemiology and Genetics and Senior Advisor on Biobanking, Center for Global Health of the U.S. NCI. She supports large program and contract management; and infrastructure planning for molecular epidemiology. She is active in the International Society for Biological and Environmental Repositories (ISBER) (ISBER President 2011-12 and current Chair of the OAC). She is a member of the NIH AllofUS Program – Biospecimens/Phys Meas. working group; and SC member and E&T Chair of the IARC-led LMIC Biobank and Cohort Building Network (BCNet); Ms. Henderson is actively involved in large-scale biospecimen process improvements in operations, technology transfer, sustainability and repository automation.

Helen Morrin

For her long-term contribution to ISBER and her efforts in the Science Policy Committee and the update of the material on the webpages.

  Helen has been involved in biobanking since 2000 in her role as curator of the Cancer Society Tissue Bank at the University of Otago Christchurch, New Zealand and has a background in cancer research and diagnostic pathology. Her special interest is in ELSI, (ethics, legislation & social issues), arising from the desire for practical regulatory oversight that meets the needs of all stakeholders and particularly those of New Zealand’s indigenous people. To achieve this she has been active in submissions that have been incorporated into New Zealand biobanking regulation, which in 2011, led to participation on ISBER’s Science Policy Committee, being Vice Chair since 2015. Helen has participated on the Nominations Committee 2012-2016, working groups and special interest groups, and involvement with ISBER’s affiliate partner Australasian Biospecimen Network Association since 2003. She is an editorial board member of ISBER’s official journal “Biopreservation and Biobanking”.

Xiaomin Wang

For introducing the field of biobanking to China.

Prof. Xiaomin Wang, MD, PhD. He is Director of Department of Neurobiology and Vice President of Capital Medical University, Director of Beijing Institute for Brain Disorders, China. He is the Editor in Chief of Journal of Translational Neurosciences, the President of Chinese Association of Physiological Sciences, President of Federation of the Asian and Oceanian Physiological Societies (FAOPS), council member of International Union of Physiological Sciences (IUPS) and International Society for Biological and Environmental Repositories (ISBER). He is the Chairman of International Alliance for Translational Neuroscience. He was President of Beijing Society for Neuroscience and Vice President of Chinese Society for Neuroscience. He has worked as a visiting scientist in University of Munich, Germany, Rockefeller University and Cold Spring Harbor Laboratory, USA. Prof. Wang’s research focus is on Parkinson’s and Alzheimer’s disease. He was a chief scientist of National Key Basic Research Program for Parkinson’s and Alzheimer’s disease.

Xuexun Zhou

For his long-term commitment to biobanking in China and for promoting ISBER to Chinese biobanks.

 I consider myself a dedicated volunteer of the Chinese Biobanking field, being a bridge between the Biobanking in China and internationally. My involvement with Biobanking in China started in 2001, when I founded Avantech Bioscience. Since 2011 I have attended the ISBER Annual conferences each year, and have begun promoting ISBER in China, leading more Chinese Biobankers to join into the global society and enhance the international communication, networking and interaction. I have been central in organizing the translation and promotion of the ISBER Best Practices in Chinese; have initiated the Biospecimen Science Group for Chinese Biobankers; expanded the eBiobank network and initiated the concept of the Next Generation Living Biobank together with Prof. Xuefeng Liu and other professors. I consider myself the official photographer of the ISBER meetings and as such I have recorded many impressive moments for the Biobankers all over the world. As one of the most dedicated volunteers of the Biobankig field, I remain willing to continue with great efforts for the improvement and progress of the field, especially towards achieving the vision of making Biospecimen science and Biospecimen information accessible and freely shared for the good of science and humanity.

Click here to view past ISBER Award Winners


Visit Us On TwitterVisit Us On FacebookVisit Us On Google PlusVisit Us On Linkedin